Cunningham S, Prasad A, Collyer L, Carr S, Lynn I B, Wallis C
Portex Anaesthesia, Intensive Care and Respiratory Medicine, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK.
Arch Dis Child. 2001 May;84(5):432-3. doi: 10.1136/adc.84.5.432.
Nebulised colistin is regularly used as antipseudomonal therapy in children with cystic fibrosis. We assessed bronchoconstriction in response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV(1), MEF(25%), and SaO(2) for 15 minutes. In 20 children the reduction was greater than 10% from baseline FEV(1), and was still at that level in five at 30 minutes. Subjective assessment, baseline FEV(1), and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.
雾化多黏菌素常用于囊性纤维化患儿的抗假单胞菌治疗。我们评估了58名儿童雾化吸入多黏菌素后的支气管收缩情况。雾化多黏菌素使FEV(1)、MEF(25%)和SaO(2)在15分钟内显著降低。20名儿童的FEV(1)较基线下降超过10%,其中5名儿童在30分钟时仍处于该水平。主观评估、基线FEV(1)和血清IgE均无法识别易发生支气管收缩的儿童。建议对接受多黏菌素治疗的儿童进行支气管收缩情况的仔细评估。